We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.22 | -0.15% | 149.70 | 149.89 | 147.82 | 149.89 | 6,532,721 | 00:38:06 |
From May 2019 to May 2024
--The European Union is in talks with a number of drugmakers to secure the purchase of potential Covid-19 vaccines, Reuters reports, citing unnamed sources.
--Moderna Inc., Sanofi SA, Johnson & Johnson and biotech firms BioNtech SE and CureVac AG are the companies mentioned by Reuters.
--The negotiations for advance purchase deals confirm Europe's "more assertive stance" following U.S. attempts to secure treatments and vaccines, Reuters said.
Full story: https://reut.rs/3hlrSuL
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
July 17, 2020 08:59 ET (12:59 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
